Cronos Group Inc (CRON)
$5.77
0.25 (4.53%)
CRON Stock Quote Delayed 20 Minutes
Previous Close
$5.77
Market Cap
1.02B
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
4.31M
Day's Range
5.57 - 5.89
52-Week Range
4.00 - 18.42
Dividend & Yield
N/A (N/A)
CRON Stock Predictions, Articles, and Cronos Group Inc News
Cronos Stock Watchers Should Wait For Further Declines Before Buying
Add in the Altria connection, and Cronos stock could be a big winner. But that's over a long time horizon. Until then, the best play is to wait for shares to reach a more reasonable valuation.
Cronos Stock Just Raised a Massive Red Flag
Cronos has delayed its quarterly and annual earnings report by at least two weeks while it conducts an audit of its financials. Until that audit is complete, the stock will likely underperform.
How Aurora Stock Is Continuing Its Excruciating Slide
Aurora Cannabis continues to slump along with the rest of the cannabis industry, with Aurora stock down 81% over the past 12 months.
Patience Will Be Rewarded for Investors in Beaten-Up Cronos Stock
It may take awhile for it to materialize, but beaten-up Cronos stock could eventually turn into a multi-bagger for investors.
4 Top Stock Trades for Wednesday: TSLA, TLRY, GLD, CRON
Tesla, Tilray, Cronos Group and the gold ETF (GLD) were our top stock trades for Wednesday. That said, here's a look at the charts.
2020 Could Be the Year Cronos Comes Alive
Cronos Group reports its fourth-quarter and full-year results on Feb. 27. Owners of CRON stock shouldn’t expect much in the near term.
30 Marijuana Stocks to Buy as the Future Turns Green
Thanks to favorable public sentiment and political tailwinds, the list of marijuana stocks to buy is both extensive and diverse.
Forget Legalization: CBD Is Good Enough for CRON Stock
Under conventional thinking, CRON stock can’t reach its full potential without the U.S. fully legalizing weed. But the “dumbed-down” CBD market is really what the American consumer desires, which benefits Cronos via its Lord Jones acquisition.
Organigram Stock a Standout Long-Term Winner in the Cannabis Sector
With plenty of demand and legalization efforts, the long-term growth story is still very much intact with Organigram stock.
CRON Stock Could Ride the Cannabis Resurgence into a Year-Long Rally
As a high-quality pick in a resurgent cannabis sector, CRON stock could be due for big returns in calendar 2020.
Thursday’s Vital Data: Bristol-Myers Squibb, Cronos and Canopy Growth
Options trading was hot in Bristol-Myers Squibb, Cronos and Canopy Growth stock on Tuesday. Here’s what the data suggests moving forward.
7 Stocks to Buy for January and Beyond
The outgoing 2019 was truly a year to remember, with many events that will surely carry over into 2020 and beyond. Here are the stocks to buy to advantage these developments.
U.S. Cannabis Stocks Will Make Cheap, Smart Buys in 2020
Matt McCall predicts that 2020 will be a better year for U.S. cannabis stocks. He's also calling for a big rally in bitcoin.
Why Canopy Growth Stock is a Buy Today as Cannabis’ Bad Year Nears End
It’s unlikely to be the next Netflix or Microsoft, but Canopy Growth stock has made the case for today’s investors to take a nibble
Pair-Trading Cannabis Stocks: Go Long THC and Short CBD
Cannabis stocks have taken a huge hit in 2019 and will likely remain volatile while the industry goes through its growing pains. Long-term cannabis bulls can consider mitigating their portfolio risk by going long top legal cannabis producers and short CBD-focused stocks.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
D
